Robert Carter
Chief Financial OfficerMr. Robert Carter, also known as Rob, is Chief Financial Officer of The Oncology Institute for Hope and Innovation from 2024. He is Chief Financial Officer of Starling Oncology, Inc. (formerly known as The Oncology Institute, Inc.) from October 14, 2024. Mr. Carter joined the Starling Oncology, Inc. (formerly known as The Oncology Institute, Inc.) in December 2021 as Vice President of Finance and was promoted to Senior Vice President in 2023. In this role, he oversaw corporate finance, financial planning and analysis (FP&A), treasury and investor relations, playing a crucial role in shaping the Company’s financial strategy. Mr. Carter’s extensive background spans various healthcare sectors, including pharmaceutical finance, Medicare Advantage, Medi-Cal and physician group practices. Before joining the Company, Mr. Carter served as Head of FP&A at Hoag Health System, a multi-specialty physician group practice and management services organization (MSO) from March 2020 to December 2021. Mr. Carter also previously held several leadership positions in FP&A at SCAN Health Plan and McKesson US Pharma. Mr. Carter holds a BS in finance from California State University, East Bay.
Positions
- Company NameStarling Oncology, Inc.Stock CodeSTLNPositionChief Financial OfficerColleagues
- DVDaniel VirnichCEO & Executive Director
- AMAnne M. McGeorgeIndependent Chairman
- YDYale D. PodnosChief Medical Officer
- ALAustin LeeVP of Accounting & Controller
- RPRakesh PandaChief Information Officer
- KMKaren Marie Walker JohnsonIndependent Director
- MKMohit KaushalIndependent Director
- MDMark D. StolperIndependent Director
